Preterm Birth and PROM Testing Market Size, Share, Segmentation & Forecast Analysis 2024-2032

IMARC Group, a leading market research company, has recently released a report titled "Preterm Birth and PROM Testing Market Report by Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitrazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), and Others), Application (PROM, Preterm Labor, Chorioamnionitis), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032". The study provides a detailed analysis of the industry, including the preterm birth and prom testing market trends, size, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global preterm birth and PROM testing market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.

Request to Get the Sample Report: https://www.imarcgroup.com/preterm-birth-prom-testing-market/requestsample

Factors Affecting the Growth of the Preterm Birth and PROM Testing Industry:

• Increasing Prevalence of Preterm Birth

The rising incidence of preterm birth globally is a significant driver of market growth. Preterm birth is a leading cause of neonatal mortality and morbidity, with long-term health implications for affected infants. Factors contributing to the increasing prevalence of preterm birth include maternal age, multiple pregnancies, lifestyle factors such as smoking and obesity, medical conditions like hypertension and diabetes, and environmental factors. As the burden of preterm birth continues to rise, there is a growing need for effective screening and diagnostic tests to identify individuals at risk and implement interventions to prevent or manage preterm birth, driving the demand for preterm birth testing services.

• Advancements in Diagnostic Technologies

Technological advancements in diagnostic techniques play a crucial role in driving market growth. Innovations in imaging modalities such as ultrasound, biomarker analysis, genetic testing, and fetal fibronectin testing enable more accurate and reliable detection of preterm birth and PROM. These advancements allow healthcare providers to assess fetal development, evaluate cervical length, monitor amniotic fluid levels, and detect biochemical markers associated with preterm labor and rupture of membranes. As diagnostic technologies continue to evolve, offering greater sensitivity, specificity, and accessibility, healthcare providers can improve the early detection and management of preterm birth and PROM, driving market expansion.

• Growing Emphasis on Prenatal Care and Risk Assessment

There is a growing emphasis on prenatal care and risk assessment among healthcare providers and pregnant women, driving the demand for preterm birth and PROM testing services. Early identification of risk factors for preterm birth and PROM allows healthcare providers to implement preventive measures and interventions to optimize pregnancy outcomes. Additionally, increasing awareness about the importance of prenatal care and early detection of complications among pregnant women encourages them to seek testing and screening services during pregnancy. As prenatal care becomes more integrated and comprehensive, including routine screening for preterm birth risk factors, the demand for preterm birth and PROM testing is expected to increase, fueling market growth.

Preterm Birth and PROM Testing Market Report Segmentation:

By Test Type:

• Pelvic Exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitrazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others  

Ultrasound is the largest market by test type because it is widely used for assessing fetal development, detecting preterm birth risk factors, and evaluating amniotic fluid levels, making it a crucial tool in prenatal care and preterm birth prevention strategies.

By Application:

• PROM
• Preterm Labor
• Chorioamnionitis

Preterm labor is the largest market by application due to the significant health risks associated with preterm birth, including neonatal complications and long-term disabilities, driving the demand for testing and interventions aimed at identifying and managing preterm labor to improve pregnancy outcomes.

By End User:

• Hospitals
• Diagnostic Laboratories
• Others

Hospitals are the largest market by end user because they serve as primary healthcare facilities where pregnant women receive prenatal care, undergo diagnostic testing for preterm birth and premature rupture of membranes (PROM), and receive interventions and treatments to manage preterm labor and associated complications.

Regional Insight:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America is the largest market by region due to factors such as advanced healthcare infrastructure, high prevalence of preterm births, robust research and development activities, and favorable reimbursement policies, which collectively drive the adoption and utilization of preterm birth and PROM testing technologies in the region.

Global Preterm Birth and PROM Testing Market Trends:

The increasing prevalence of preterm birth worldwide represents one of the key factors influencing the growth of the market across the globe. This is primarily attributed to factors, such as maternal age, multiple pregnancies, lifestyle factors, and medical conditions, which are fueling the demand for effective screening and diagnostic tests to identify individuals at risk and initiate timely interventions.

Advancements in medical technology and diagnostic techniques, including ultrasound imaging, biomarker analysis, and fetal fibronectin testing, enable more accurate and reliable detection of preterm birth and PROM, driving market expansion. Additionally, rising awareness among healthcare providers and pregnant women about the importance of prenatal care and early detection of risk factors for preterm birth contributes to market growth by driving demand for screening and testing services.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=8617&flag=C

Top Companies Operated in Preterm Birth and PROM Testing Industry:

• Clinical Innovations LLC (Laborie Medical Technologies Inc.)
• Cooper Surgical Inc. (The Cooper Companies Inc.)
• Hologic Inc.
• IQ Products
• NX Prenatal Inc.
• Qiagen N.V
• Sera Prognostics

Key Highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145